Search In this Thesis
   Search In this Thesis  
العنوان
Oral Lactoferrin as a Source of Iron Supplementation in Pediatric Patients with chronic Kidney Disease /
المؤلف
AlArian,Rawan Ashraf Mohamed
هيئة الاعداد
باحث / روان أشرف محمد العريان
مشرف / إيهــــاب زكـــي الحكيـــم
مشرف / محمــــد سامـــــي الفارســــي
تاريخ النشر
2017
عدد الصفحات
131.p:
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب
تاريخ الإجازة
1/1/2017
مكان الإجازة
جامعة عين شمس - كلية التمريض - Pediatrics
الفهرس
Only 14 pages are availabe for public view

from 131

from 131

Abstract

Recently, it has been shown significant decreases of total serum iron and serum ferritin combined with increases of serum interleukin 6 (IL-6) have been observed in hemodialysis patients treated with oral ferrous sulphate. Bovine lactoferrin (bLf) represents an attractive and promising alternative to ferrous sulphate oral administration. Studies has showed that oral administration of bLf, 30% iron saturated, significantly improved hematological markers, including number of red blood cells (RBCs), hemoglobin, total serum iron, serum ferritin concentrations compared to those treated with ferrous sulphate. Aim: To study the effect of oral bovine lactoferrin on iron deficiency patients with chronic kidney disease stages 2-4. In our follow up clinical study, 45 chronic kidney disease (CKD) pediatric patients who are iron deficient within the pediatric nephrology conservative clinic, children’s hospital, Ain Shams University, were subjected to pravotin (lactoferrin) intervention with monitoring of blood Hb and RBC volume before intervention and after 6 months with regular monthly check of both…and monitoring of Iron profile including serum iron, serum ferritin, total iron binding capacity (TIBC) before and after 6 months of treatment. The current study found that blood Hb and RBC volume significantly increased beginning from first month after oral lactoferrin therapy, serum iron significantly increased six months after intervention, serum ferritin significantly increased six months after intervention, and serum TIBC significantly decreased after intervention. The current study had also shown no significant difference between males and females regarding lab changes 6 months after intervention, lab improvements were significantly lowest among cases with stage IV, followed by stage III and highest among cases with stage II.
Keywords: interleukin 6, Bovine lactoferrin, red blood cells, chronic kidney disease.